111 (YI) has a profit margin of -0.73%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for YI is -0.73% as of March 2026. That compares with -0.48% in the prior-year period — down 53.9% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside 111's historical trend and sector peers before judging valuation or financial health.
Over the past year, YI's profit margin moved from -0.48% to -0.73% — a 53.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 111's valuation or profitability profile.
Against Healthcare companies, YI currently prints -0.73% for profit margin, while the sector average sits near 14.34%. That is roughly 105.1% below the sector mean. Large gaps often invite a closer look at 111's growth, margins, and balance sheet.
Profit Margin shows how effectively 111 converts resources into returns. At -0.73%, YI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -0.48% in the prior-year period — down 53.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting YI's profit margin (-0.73%), review year-over-year change from -0.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.